Gene · 140
Papers1,628
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,628
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma. | Nat Commun | 2022 | 35973991 | PubTator, text mining | PubMed |
| The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis. | Front Immunol | 2022 | 35967385 | PubTator, text mining | PubMed |
| Endoglin and MMP14 Contribute to Ewing Sarcoma Spreading by Modulation of Cell-Matrix Interactions. | Int J Mol Sci | 2022 | 35955799 | PubTator, text mining | PubMed |
| Phenotype Diversity of Macrophages in Osteoarthritis: Implications for Development of Macrophage Modulating Therapies. | Int J Mol Sci | 2022 | 35955514 | PubTator, text mining | PubMed |
| Effects of smoking on the tissue regeneration-associated functions of human endometrial stem cells via a novel target gene SERPINB2. | Stem Cell Res Ther | 2022 | 35932085 | PubTator, text mining | PubMed |
| Alternative adenosine Receptor activation: The netrin-Adora2b link. | Front Pharmacol | 2022 | 35910389 | PubTator, text mining | PubMed |
| Quantitatively defining species boundaries with more efficiency and more biological realism. | Commun Biol | 2022 | 35902726 | PubTator, text mining | PubMed |
| Cancer-Associated Mutations of the Adenosine A2A Receptor Have Diverse Influences on Ligand Binding and Receptor Functions. | Molecules | 2022 | 35897852 | PubTator, text mining | PubMed |
| Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer's Disease. | Biomedicines | 2022 | 35892700 | PubTator, text mining | PubMed |
| How Should the Worldwide Knowledge of Traditional Cancer Healing Be Integrated with Herbs and Mushrooms into Modern Molecular Pharmacology? | Pharmaceuticals (Basel) | 2022 | 35890166 | PubTator, text mining | PubMed |
| High PANX1 Expression Leads to Neutrophil Recruitment and the Formation of a High Adenosine Immunosuppressive Tumor Microenvironment in Basal-like Breast Cancer. | Cancers (Basel) | 2022 | 35884429 | PubTator, text mining | PubMed |
| Caffeine Attenuates Electroacupuncture Effect on Pressure Pain Threshold and Tolerance in Healthy Individuals: A Randomized Controlled Trial. | Front Neurol | 2022 | 35873768 | PubTator, text mining | PubMed |
| Adenosine receptor signalling in Alzheimer's disease. | Purinergic Signal | 2022 | 35870032 | PubTator, text mining | PubMed |
| Machine Learning for Discovery of New ADORA Modulators. | Front Pharmacol | 2022 | 35814244 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents. | Molecules | 2022 | 35807236 | PubTator, text mining | PubMed |
| What Inhibits Natural Killers' Performance in Tumour. | Int J Mol Sci | 2022 | 35806034 | PubTator, text mining | PubMed |
| Glioblastoma: Current Status, Emerging Targets, and Recent Advances. | J Med Chem | 2022 | 35786935 | PubTator, text mining | PubMed |
| Clinical Pharmacokinetics and Pharmacodynamics of Fostamatinib and Its Active Moiety R406. | Clin Pharmacokinet | 2022 | 35781630 | PubTator, text mining | PubMed |
| Activation of adenosine A3 receptor attenuates progression of osteoarthritis through inhibiting the NLRP3/caspase-1/GSDMD induced signalling. | J Cell Mol Med | 2022 | 35775127 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/140/papers?page=15